Molecular targeted therapy of head and neck cancer: Review and clinical development challenges
Authors:
- Sandrine FaivreSFSandrine Faivre
- Lillian L. SiuLSLillian L. Siu
- 30 November 2007
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 43 (17) , 2457-2466
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 daysBritish Journal of Cancer, 2006
- Protein Kinase Cζ Mediates Epidermal Growth Factor–Induced Growth of Head and Neck Tumor Cells by Regulating Mitogen-Activated Protein KinaseCancer Research, 2006
- The Signaling and Biological Implications of FAK Overexpression in CancerClinical Cancer Research, 2006
- Overexpression of Focal Adhesion Kinase in Head and Neck Squamous Cell Carcinoma Is Independent of fak Gene Copy NumberClinical Cancer Research, 2006
- Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2006
- Histone Deacetylase Enzymes as Potential Drug Targets in Cancer and Parasitic DiseasesBioMed Research International, 2006
- Dasatinib (BMS-354825) Tyrosine Kinase Inhibitor Suppresses Invasion and Induces Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma and Non–Small Cell Lung Cancer CellsClinical Cancer Research, 2005
- Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or LymphomaJournal of Clinical Oncology, 2005
- Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cellsJournal of Cancer Research and Clinical Oncology, 2003
- Cell-cycle control: POLO-like kinases join the outer circleTrends in Cell Biology, 1997